Page 4 - Burning Rock Biotech Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Feb 12, 2021 - Greenwoods Asset Management Ltd Buys Pinduoduo Inc, Taiwan Semiconductor Manufacturing Co, Apple Inc, Sells Alibaba Group Holding, JD com Inc, Facebook Inc

These are the top 5 holdings of Greenwoods Asset Management Ltd Pinduoduo Inc (PDD) - 6,403,552 shares, 26.13% of the total portfolio. Shares added by 94.73% Sea Ltd (SE) - 2,129,532 shares, 9.74% of the total portfolio. Shares added by 2.73% Facebook Inc (FB) - 1,520,670 shares, 9.54% of the total portfolio. Shares reduced by 23.51% ZTO Express (Cayman) Inc (ZTO) - 13,588,116 shares, 9.10% of the total portfolio. Shares reduced by 11.06% Taiwan Semiconductor Manufacturing Co Ltd (TSM) - 2,615,770 shares, 6.55% of the total portfolio. Shares added by 856.41% New Purchase: Tesla Inc (TSLA) Greenwoods Asset Management Ltd initiated holding in Tesla Inc. The purchase prices were between $388.04 and $705.67, with an estimated average price of $512.96. The stock is now traded at around $803.520000. The impact to a portfolio due to this purchase was 2.98%. The holding were 183,980 shares as of 2020-12-31.

Square incBaidu incFacebook incVideo communications incBurning rock biotech ltdBallard power systems incPuxin ltdAlibaba group holdingGreenwoods asset management ltd current portfolioTaiwan semiconductor manufacturing coTesla incCree incVipshop holdingsSea ltdAirbnb incEducation technology group inc

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ADPT) - The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ADPT) - The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Satyavrat shuklaGossamer bio incBurning rock biotech ltdCastle biosciences incOpiant pharmaceuticals incNeovasc incGhassan aboud groupOcular therapeutix incMediwound ltdKezar life sciences incOncology incKezar life sciencesOncocyte corpInmed pharmaceuticals incLegend biotech corpDevelopment of opioid overdose drug

OncoCyte s stock soars after licensing deal with China-based company, days after insiders acquired shares

Shares of OncoCyte Corp. OCX, -1.98% rocketed 63% on very heavy volume in premarket trading Tuesday, after the molecular diagnostics company announced overnight that it entered into an exclusive licensing agreement with China-based Burning Rock Biotech Ltd. BNR, -0.72% to bring OncoCyte s DetermaRX test for early-stage lung cancer patients to China. Trading volume spiked to 8.3 million shares, compared with the full-day average of about 419,500 shares. This agreement with Burning Rock accelerates the ongoing expansion of our DetermaRx test to patients and physicians outside the U.S., and exemplifies our global growth strategy, said OncoCyte Chief Executive Ron Andrews. The news and stock s rally comes as several OncoCyte executives and directors disclosed that they acquired shares on Dec. 11, as repayment of deferred compensation in lieu of cash at a price of $2.07 per share, which was 2.4% below Monday s closing price. The stock has lost 5.8

Oncocyte determaRon andrewsBurning rock biotech ltdOncocyte corpChina based burning rock biotechBurning rockOncocyte chief executive ronரோன் ஆண்ட்ரூஸ்எரியும் பாறை பயோடெக் லிமிடெட்சீனா அடிப்படையிலானது எரியும் பாறை பயோடெக்எரியும் பாறை